NCT04126499
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- BIG PAC Madrid, Spain
Clinical trial condition
Hypereosinophilic Syndrome
Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.
69 public trials
4 recruiting studies
Hypereosinophilic Syndrome trial results
NCT03931954
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +13 more
- Locations
-
- Research Site Buenos Aires, Argentina
- Research Site Rosario, Argentina
- Research Site Curicó, Chile
- Research Site Santiago, Chile
Completed
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190
- Conditions
- Asthma, Asthma; Eosinophilic, Bronchial Diseases, +13 more
- Locations
-
- Azienda Ospedaliero Universitaria Ferrara Ferrara, Italy
- Professor of Respiratory Medicine Department of Medical and Surgical Sciences University of Foggia - Italy Foggia, Italy
- UOC Pneumologia Ospedale L.Sacco - Polo Univestiario ASST Fatebenefratelli - Milano Milan, Italy
- Malattie dell' Apparato Respiratorio Dipartimento di Scienza Mediche e Chirurgiche Materni-Infantili e dell'Adulto. Azienda Ospedaliero Universitaria di Modena Modena, Italy
NCT03925415
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +13 more
- Locations
-
- Research Site Blumenau, Brazil
- Research Site Goiânia, Brazil
- Research Site Londrina, Brazil
- Research Site Porto Alegre, Brazil
NCT03610685
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- Asthma and copd research centre Glasgow, United Kingdom
Completed
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
NCT02555371
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site New Haven, Connecticut, United States
Completed
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
NCT02377427
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Oklahoma City, Oklahoma, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Madison, Wisconsin, United States
Completed
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
NCT02135692
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Rolling Hills Estates, California, United States
- GSK Investigational Site Denver, Colorado, United States
NCT02560610
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University of Oxford Oxford, Oxfordshire, United Kingdom
NCT02654145
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Roseville, California, United States
- GSK Investigational Site San Diego, California, United States